Afya Limited (NASDAQ:AFYA – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $15.28 and last traded at $15.82, with a volume of 214927 shares trading hands. The stock had previously closed at $16.59.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on AFYA shares. UBS Group started coverage on shares of Afya in a report on Friday, August 30th. They set a “neutral” rating and a $19.50 price target for the company. The Goldman Sachs Group initiated coverage on shares of Afya in a research note on Tuesday. They issued a “sell” rating and a $16.00 price objective for the company.
View Our Latest Analysis on Afya
Afya Stock Performance
Institutional Trading of Afya
Several institutional investors and hedge funds have recently made changes to their positions in AFYA. Public Employees Retirement System of Ohio acquired a new stake in Afya during the third quarter worth approximately $34,000. Quarry LP acquired a new position in Afya in the third quarter valued at $75,000. Centiva Capital LP purchased a new position in Afya during the third quarter worth about $213,000. Quantbot Technologies LP boosted its stake in Afya by 73.8% in the 3rd quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after buying an additional 5,636 shares during the last quarter. Finally, Lifestyle Asset Management Inc. grew its holdings in Afya by 26.9% in the 2nd quarter. Lifestyle Asset Management Inc. now owns 14,784 shares of the company’s stock valued at $261,000 after buying an additional 3,133 shares during the period. 88.02% of the stock is currently owned by hedge funds and other institutional investors.
About Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories
- Five stocks we like better than Afya
- Why is the Ex-Dividend Date Significant to Investors?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Industrial Products Stocks Investing
- Netflix Is On Track To Hit $1,000 By Christmas
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.